Donate to Cancer Research
Make a difference in the fight against cancer by donating to cancer research
Gateway for Cancer Research is a 501(c)(3) non-profit organization. Charitable ID #: 73-1386920
CTCA is proud to share the expertise of our physicians through a series of free CME education, both virtual and live. Driven by the goal of improving patient care, our CME program is dedicated to providing a robust, well-rounded portfolio of CME activities that contribute to the greater good of our clinical communities.
COVID-19 changed the landscape for many healthcare providers. In addition to creating a need for appointments with minimal contact, the Centers for Medicare and Medicaid relaxed and modified policy surrounding telehealth appointments to facilitate quick transition to virtual appointments. This education will share best practices and compliance considerations for deploying a pandemic response telehealth program, and recommendations for transitioning this program to a post-COVID world.
Upon completion of this activity, participants will be able to:
Faculty:
Lymphedema is a common side effect in patients with cancer. While surgical interventions may sometimes be necessary, there are many less invasive options as well which may effectively manage the condition for some patients. This program aims to discuss the latest data on methods of managing lymphedema, and how to determine which method is best for each patient.
Upon completion of this activity, participants will be able to:
Faculty:
CME Forum is an educational event designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to integrative care for patients with cancer. Recordings of presentations, case studies and Q & A sessions are available on demand to enhance clinician knowledge and competence. Click on the registration links to learn more about topics and faculty for each on demand event.
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic/genomic testing, pathology and radiological imaging. Cases discussed include: gallbladder carcinoma, triple negative breast cancer, endometrial cancer and adenocarcinoma of unknown primary.
Upon completion of this activity, participants will be able to:
Faculty:
This program highlights 5 presentations from a 2019 spring live lecture series. Videos are packaged into short chapters, featuring topics such as: screening high-risk patients, cancer pain management, immunotherapy treatment & adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment and drug-drug interactions.
Upon completion of this activity, participants will be able to:
Faculty:
Clinicians require education surrounding lung nodules and need to be updated on new and emerging therapies that will lead to individualized treatment and improved outcomes. As technology improves and new data emerges, recommendations for how and when to follow up with patients with lung nodules continues to evolve. This activity provides a platform to understand the latest guidance.
Upon completion of this activity, participants will be able to:
Faculty:
Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.
Upon completion of this activity, participants will be able to:
Faculty:
Due to recent recommendations regarding COVID-19 from the CDC and WHO, we are postponing our live CME events scheduled for March 2020. We will continue to monitor the situation and reschedule these events once it is safe to do so. At this time, events for April and May will proceed as scheduled but we will keep any registrants posted if those programs need to be changes as well. Please contact Sarah Lees, National CME Program Manager, with any questions at sarah.lees@ctca-hope.com
This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of patients suffering from rectal cancer. In recent years, the average age of patients with rectal cancer has decreased. These younger patients require different treatment approaches. This activity is focused on sharing the various protocols for managing rectal cancer in young adults, focusing on how recommendations differ in a younger population, and emerging evidence of the effectiveness of various approaches in patients under 50.
Upon completion of this activity, participants will be able to:
Faculty:
Donate to Cancer Research
Make a difference in the fight against cancer by donating to cancer research
Gateway for Cancer Research is a 501(c)(3) non-profit organization. Charitable ID #: 73-1386920